MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS

被引：0
|
作者：
Naidoo, Jarushka [1 ]
Noonan, Sinead [2 ]
Teo, Min Yuen [3 ]
Rho, Young Soo [1 ]
Clince, Janet [1 ]
Gately, Kathy [4 ]
O'Grady, Tony [5 ]
Kaye, Elaine [5 ]
Calvert, Paula [6 ]
Morris, Patrick G. [7 ]
O'Brien, Cathal [4 ]
O'Byrne, Kenneth [8 ]
Breathnach, Oscar S. [1 ]
机构：
[1] Beaumont Hosp, Dublin, Ireland
[2] St James Hosp, Dublin, Ireland
[3] Inc Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin 24, Ireland
[4] Univ Dublin Trinity Coll, Dublin 2, Ireland
[5] Beaumont Hosp, Dublin, Ireland
[6] Waterford Reg Hosp, Waterford, Ireland
[7] Hermitage Clin, Dublin, Ireland
[8] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Treatment; non-small cell lung cancer; Cinical Trials; Inequality;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-042
引用
收藏
页码：S1208 / S1208
页数：1
相关论文
共 50 条
  • [1] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Pifarre, A
    Monzo, M
    Martin, C
    Sanchez, JJ
    Barnadas, A
    Rosell, R
    [J]. ANNALS OF ONCOLOGY, 1998, 9 : 92 - 92
  • [2] Clinical implications of telomerase activity in non-small cell lung cancer (NSCLC)
    Ramírez, JL
    Sancho, E
    Núñez, L
    Sánchez, JJ
    Balañá, C
    López, P
    Martín, C
    Monzó, M
    Rosell, R
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S39 - S39
  • [3] Treatment delays in non-small cell lung cancer (NSCLC) and their prognostic implications
    Diaconescu, R.
    Lafond, C.
    Choiniere, L.
    Sirois, C.
    Laliberte, B.
    Doyon, M.
    Whittom, R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] TREATMENT DELAYS IN NON-SMALL CELL LUNG CANCER (NSCLC) AND THEIR PROGNOSTIC IMPLICATIONS
    Diaconescu, R.
    Lafond, C.
    Choiniere, L.
    Sirois, C.
    Laliberte, B.
    Doyon, M.
    Whittom, R.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : S112 - S112
  • [5] Treatment of non-small cell lung cancer (NSCLC)
    Zarogoulidis, Konstantinos
    Zarogoulidis, Paul
    Darwiche, Kaid
    Boutsikou, Efimia
    Machairiotis, Nikolaos
    Tsakiridis, Kosmas
    Katsikogiannis, Nikolaos
    Kougioumtzi, Ioanna
    Karapantzos, Ilias
    Huang, Haidong
    Spyratos, Dionysios
    [J]. JOURNAL OF THORACIC DISEASE, 2013, 5 : S389 - S396
  • [6] MOLECULAR MARKERS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Heigener, D.
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1979 - 1979
  • [7] Evaluation of clinical and molecular changes in advanced non-small cell lung cancer(NSCLC)
    Pilnik, N
    Di Rienzo, J
    Spitale, L
    Grasso, R
    Henin, A
    Caminos, S
    [J]. LUNG CANCER: CURRENT TOPICS, 2001, : 65 - 70
  • [8] The cost of non-small cell lung cancer (NSCLC) treatment
    Vergnenegre, A.
    [J]. ONCOLOGIE, 2012, 14 (05) : 310 - 315
  • [9] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2015
    Garcia-Campelo, R.
    Bernabe, R.
    Cobo, M.
    Corral, J.
    Coves, J.
    Domine, M.
    Nadal, E.
    Rodriguez-Abreu, D.
    Vinolas, N.
    Massuti, B.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (12): : 1020 - 1029
  • [10] SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013
    C. Camps
    E. Felip
    R. García-Campelo
    J. M. Trigo
    P. Garrido
    [J]. Clinical and Translational Oncology, 2013, 15 : 977 - 984
12345